Company / Operating Cash Flow per Share
SUTRO BIOPHARMA, INC. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$23.06
FY2025
5-year range
-$23.06 / $0.06
FY2021-FY2025
Trend
-39740.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -39741% YoY in FY2025, a notable deviation from the 7-year average annual change of -5681%.
Based on SEC 10-K filings.
-23.06 in FY2025.
Declined from $-1.42 to $-23.06 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 39740.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.06 | -39740.6% |
| FY2024 | $0.06 | +104.1% |
| FY2023 | -$1.42 | +2.9% |
| FY2022 | -$1.46 | -3.0% |
| FY2021 | -$1.42 | -358.8% |
| FY2020 | $0.55 | +133.8% |
| FY2019 | -$1.62 | +94.3% |
| FY2018 | -$28.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026